{"slideshow_credits": null, "snippet": "The Auvi-Q, which drew an ardent fan base, was taken off the market in 2015. It is unclear whether its comeback next year will help lower the price of the EpiPen....", "abstract": "Drug company Kaleo announces it will bring back Auvi-Q, EpiPen alternative taken off market in 2015, in move cautiously welcomed by lawmakers concerned about rising price of EpiPens; it is unclear whether drug will help lower prices of epinephrine-delivery devices given fact that since it previously cost more than EpiPen and generic version is expected to be launched.", "section_name": "Business Day", "print_page": "7", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS"}, "web_url": "http://www.nytimes.com/2016/10/27/business/an-epipen-rival-is-about-to-return-to-the-shelves.html", "lead_paragraph": "The Auvi-Q, which drew an ardent fan base, was taken off the market in 2015. It is unclear whether its comeback next year will help lower the price of the EpiPen.", "headline": {"main": "An EpiPen Rival Is About to Return to the Shelves", "print_headline": "Rival of EpiPen Readies for Return to the Shelves"}, "_id": "58109a1295d0e022439c5497", "word_count": "951", "multimedia": [{"height": 126, "url": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 322, "url": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-articleLarge.jpg", "legacy": {"xlarge": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "322"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-10-26T11:57:04+0000", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Epinephrine (Drug)", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Medical Devices", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Allergies", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "5"}, {"name": "organizations", "value": "Kaleo Inc", "is_major": "Y", "rank": "6"}, {"name": "organizations", "value": "Mylan Inc", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}